• Temozolomide Workflows for DNA Repair Research

  2026-08-30

  Temozolomide provides a controllable way to induce DNA methylation, cell-cycle arrest, and cytotoxicity in glioma and broader cancer models. This practical guide connects formulation, dose–time testing, ATRX-focused study design, combination assays, and troubleshooting for more reproducible DNA repair mechanism research.

• Reactive Oxygen Species Assay Kit for Live-Cell ROS

  2026-08-29

  Turn treatment-induced redox changes into actionable live-cell data with a DCFH-DA workflow built around controls, normalization, and timing. The assay is especially useful for linking ROS elevation with apoptosis, DNA damage, nanoparticle delivery, and FLASH-radiotherapy response.

• Modular Inflammation Networks in Mouse Brain

  2026-08-29

  Xiong et al. developed a large-scale bulk RNA-seq framework that uses ENU-derived genetic perturbations to separate inflammatory gene-expression modules in the mouse CNS. The study shows that disease-relevant variants can produce distinct microglial, astrocytic, and broader neuroinflammatory states, providing a practical strategy for interpreting complex brain transcriptomes.

• DAF-2 diacetate for NO Imaging Workflows

  2026-08-28

  DAF-2 diacetate converts intracellular nitric oxide activity into a stable fluorescent signal for live-cell, tissue, and biochemical experiments. This practical guide connects assay design with sulfur-dependent regulation of soybean nodule senescence, while emphasizing controls, quantitative normalization, and limitations.

• DiscoveryProbe Natural Product Library Plus Workflow

  2026-08-28

  Turn a diverse natural product library into a practical discovery engine for enzyme inhibition, antiparasitic validation, and cell-based mechanism studies. This workflow combines DMSO-ready compound handling with orthogonal biochemical, viability, and high-content readouts to separate genuine biology from assay artifacts.

• Affinity-Purified Goat Anti-Mouse IgG (H+L) Workflow

  2026-08-27

  Build more consistent Western blot, ELISA, and chromogenic tissue assays with an HRP-labeled secondary designed for mouse IgG primaries. This guide translates a liver-fibrosis mechanism study into practical assay selection, optimization, controls, and troubleshooting while clearly separating product-supported specifications from workflow recommendations.

• L-Glutathione Reduced: Redox Experimental Design

  2026-08-27

  L-Glutathione Reduced is more than a general antioxidant: it is a controllable thiol reagent for separating redox effects from metabolic causality. This guide connects glutathione chemistry with GOT1-centered pancreatic cancer research and practical assay design.

• Nav1.5 Ser571, Late INa, and Aging Cardiac Dysfunction

  2026-08-26

  The 2024 reference study identifies Nav1.5 phosphorylation at Ser571 as a mechanistic link between increased late sodium current, delayed ventricular repolarization, and age-related diastolic dysfunction. By combining age-stratified mice, phosphomimetic and phosphoablated channel mutants, cardiac recordings, and isolated-myocyte assays, it shows that altered late sodium influx can anticipate or attenuate features of the aging myopathy.

• T0070907: A PPARγ Antagonist for Causal Assays

  2026-08-26

  T0070907 is a high-affinity PPARγ antagonist for separating receptor-dependent transcription from downstream cellular phenotypes. This guide translates RXRα/PPARγ/NEDD4 findings in atherosclerosis into rigorous assay design for adipogenesis, inflammation, and cancer biology.

• 4-Ethylphenyl Sulfate: Assay Workflows

  2026-08-25

  4-Ethylphenyl sulfate connects renal biomarker studies, gut microbiota-brain interaction research, and disease-relevant biomaterial testing in one reproducible workflow. This guide covers preparation, exposure design, matrix controls, and troubleshooting for studies spanning serum analysis, autism spectrum disorder models, and uremic-toxin adsorption.

• GTP Solution (100 mM): Assay-to-Therapy Insight

  2026-08-25

  Explore how GTP Solution supports controlled RNA synthesis and how nucleotide quality influences interpretation of p21 mRNA–LNP studies. This article connects molecular assay design, product handling, and localized bladder cancer translation without confusing reagent performance with therapeutic efficacy.

• Luminescent ATP Detection Assay Kit for NSCLC

  2026-08-24

  Connect pyruvate carboxylase activity with ATP-dependent energy remodeling and ferroptosis susceptibility in NSCLC models. This streamlined luminescence workflow supports cellular ATP quantification, tissue analysis, and protein-focused follow-up without harsh acid extraction.

• Protease Inhibitor Cocktail for Plant Assays

  2026-08-23

  Discover how a Protease Inhibitor Cocktail supports plant cell protein stability while preserving assay-relevant biochemical states. This article connects plant extract handling with the TBK1–itaconic acid study to explain practical decisions about proteolysis, metal chemistry, phosphorylation, and assay interpretation.

• Perospirone: From Receptors to Kv1.5

  2026-08-22

  Perospirone is more than a receptor pharmacology tool. Its established 5-HT2A, D2, and 5-HT1A activities now sit alongside evidence for concentration-dependent Kv1.5-associated inhibition in coronary arterial smooth muscle, creating a sharper translational framework for schizophrenia research and cardiovascular safety studies.

• The 4Q Design for Stable mRNA Delivery

  2026-08-21

  The reference study introduces a 4Q framework that treats mRNA delivery as a sequence of stability, diffusion, cellular entry, and intracellular-release problems rather than as a single formulation challenge. Its PBD polycation combines catechol-mediated RNA interactions, reducible disulfide chemistry, and lipid shielding to achieve room-temperature polyplex stability and substantially stronger in vivo expression than a jetPEI comparator.

448 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page